Pura Vida Investments, LLC Immuno Gen, Inc. Call Options Transaction History

Pura Vida Investments, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 14, 2019	SELL	$1.8 - $3.3 $944,280 - $1.73 Million	-524,600 Closed	0 $0
Q1 2019 Feb 12, 2021	BUY	$2.41 - $5.91 $1.25 Million - $3.07 Million	519,354 Added 9900.0%	524,600 $1.42 Million
Q1 2019 May 14, 2019	SELL	$2.41 - $5.91 $1.18 Million - $2.88 Million	-488,154 Reduced 98.94%	5,246 $13,000
Q4 2018 Feb 11, 2021	BUY	$3.94 - $9.7 $1.92 Million - $4.74 Million	488,466 Added 9900.0%	493,400 $2.37 Million
Q4 2018 Feb 14, 2019	SELL	$3.94 - $9.7 $768,560 - $1.89 Million	-195,066 Reduced 97.53%	4,934 $274,000
Q3 2018 Feb 11, 2021	BUY	$8.6 - $11.26 $1.7 Million - $2.23 Million	198,000 Added 9900.0%	200,000 $1.89 Million
Q3 2018 Nov 14, 2018	BUY	$8.6 - $11.26 $17,200 - $22,520	2,000 New	2,000 $430,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.